From Theory to Therapy: Accelerating Ligand-Based Virtual Screening with AI and ML Technologies

<!doctype html><html lang="en"><head> <meta charset="utf-8"> <title>From Theory to Therapy: Accelerating Ligand-Based Virtual Screening with AI and ML Technologies</title> <link rel="shortcut icon" href="https://oxfordglobal.com/hubfs/OXFORD_GLOBAL-LOGO_SYMBOL.jpg"> <meta name="description" content="The latest in drug discovery & development research, from organoid & 3d cell culture though to latest technologies in drug discovery and neuroscience"> <meta name="viewport" content="width=device-width, initial-scale=1"> <meta property="og:description" content="The latest in drug discovery & development research, from organoid & 3d cell culture though to latest technologies in drug discovery and neuroscience"> <meta property="og:title" content="From Theory to Therapy: Accelerating Ligand-Based Virtual Screening with AI and ML Technologies"> <meta name="twitter:description" content="The latest in drug discovery & development research, from organoid & 3d cell culture though to latest technologies in drug discovery and neuroscience"> <meta name="twitter:title" content="From Theory to Therapy: Accelerating Ligand-Based Virtual Screening with AI and ML Technologies"> <style> a.cta_button{-moz-box-sizing:content-box !important;-webkit-box-sizing:content-box !important;box-sizing:content-box !important;vertical-align:middle}.hs-breadcrumb-menu{list-style-type:none;margin:0px 0px 0px 0px;padding:0px 0px 0px 0px}.hs-breadcrumb-menu-item{float:left;padding:10px 0px 10px 10px}.hs-breadcrumb-menu-divider:before{content:'›';padding-left:10px}.hs-featured-image-link{border:0}.hs-featured-image{float:right;margin:0 0 20px 20px;max-width:50%}@media (max-width: 568px){.hs-featured-image{float:none;margin:0;width:100%;max-width:100%}}.hs-screen-reader-text{clip:rect(1px, 1px, 1px, 1px);height:1px;overflow:hidden;position:absolute !important;width:1px} </style> <link rel="stylesheet" href="https://oxfordglobal.com/hs-fs/hub/8696823/hub_generated/template_assets/135726131582/1732113079147/git/og-stage/css/main.min.css"> <link rel="stylesheet" href="https://cdn.oxfordglobal.com/fontawesome/6.5.1/css/fontawesome.min.css"> <link rel="stylesheet" href="https://cdn.oxfordglobal.com/fontawesome/6.5.1/css/brands.min.css"> <link rel="stylesheet" href="https://cdn.oxfordglobal.com/fontawesome/6.5.1/css/solid.min.css">  <style id="hs_editor_style" type="text/css"> #hs_cos_wrapper_module_17019620504109 { display: block !important; margin-bottom: 0px !important } </style>  <script> var _hsp = window._hsp = window._hsp || []; window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} var useGoogleConsentModeV2 = true; var waitForUpdateMillis = 1000; if (!window._hsGoogleConsentRunOnce) { window._hsGoogleConsentRunOnce = true; gtag('consent', 'default', { 'ad_storage': 'denied', 'analytics_storage': 'denied', 'ad_user_data': 'denied', 'ad_personalization': 'denied', 'wait_for_update': waitForUpdateMillis }); if (useGoogleConsentModeV2) { _hsp.push(['useGoogleConsentModeV2']) } else { _hsp.push(['addPrivacyConsentListener', function(consent){ var hasAnalyticsConsent = consent && (consent.allowed || (consent.categories && consent.categories.analytics)); var hasAdsConsent = consent && (consent.allowed || (consent.categories && consent.categories.advertisement)); gtag('consent', 'update', { 'ad_storage': hasAdsConsent ? 'granted' : 'denied', 'analytics_storage': hasAnalyticsConsent ? 'granted' : 'denied', 'ad_user_data': hasAdsConsent ? 'granted' : 'denied', 'ad_personalization': hasAdsConsent ? 'granted' : 'denied' }); }]); } } gtag('js', new Date()); gtag('set', 'developer_id.dZTQ1Zm', true); gtag('config', 'G-43QK8SYTST'); </script> <script async src="https://www.googletagmanager.com/gtag/js?id=G-43QK8SYTST"></script>  <link rel="canonical" href="https://oxfordglobal.com/discovery-development/resources/accelerating-ligand-based-virtual-screening"> <meta property="og:image" content="https://oxfordglobal.com/hubfs/Website/Images/Resources/Discovery/Accelerating%20Ligand-Based%20Virtual%20Screening%20with%20AI%20and%20ML%20Technologies.jpg"> <meta property="og:image:width" content="6000"> <meta property="og:image:height" content="4000"> <meta name="twitter:image" content="https://oxfordglobal.com/hubfs/Website/Images/Resources/Discovery/Accelerating%20Ligand-Based%20Virtual%20Screening%20with%20AI%20and%20ML%20Technologies.jpg"> <meta property="og:url" content="https://oxfordglobal.com/discovery-development/resources/accelerating-ligand-based-virtual-screening"> <meta name="twitter:card" content="summary"> <meta http-equiv="content-language" content="en"> <meta name="generator" content="HubSpot"></head> <body class="discovery-development"> <div class="body-wrapper hs-content-id-177028096592 hs-site-page page "> <div data-global-resource-path="git/og-stage/templates/partials/header.html"> <header class="website-header "> <div class="navbar"> <div class="navbar-brands"> <a href="/discovery-development" class="logo-link current-brand"> <img src="https://oxfordglobal.com/hubfs/Website/Logos/Brand%20Logos/Discovery%20%26%20Development.svg" class="logo-image"> <i class="dropdown fa-solid fa-chevron-down"></i> </a> <div class="brands"> <div class="intro"> <h2> Explore our brands </h2> <div class="desc"> Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges. </div> </div> <div class="items"> <div class="item primary-brand"> <a href="/" class="logo-link"><img src="https://oxfordglobal.com/hubfs/logo.jpg" class="logo-image"></a> </div> <div class="item"> <a href="/precision-medicine" class="logo-link"><img src="https://oxfordglobal.com/hubfs/Website/Logos/Brand%20Logos/Precision%20Medicine.svg" class="logo-image"></a> </div> <div class="item active-item"> <a href="/discovery-development" class="logo-link"><img src="https://oxfordglobal.com/hubfs/Website/Logos/Brand%20Logos/Discovery%20%26%20Development.svg" class="logo-image"></a> </div> <div class="item"> <a href="/nextgen-biomed" class="logo-link"><img src="https://oxfordglobal.com/hubfs/Website/Logos/Brand%20Logos/NextGen%20Biomed.svg" class="logo-image"></a> </div> </div> </div> </div> <div class="flex flex-align-center navbar-nav"> <a href="#" class="navbar-nav-toggle"> <div class="toggle-icons"> <i class="fa-solid fa-bars toggle-open"></i> <i class="fa-solid fa-xmark toggle-close"></i> </div> </a> <ul class="navbar-nav-items"> <li class="navbar-nav-item"> <a href="#" class="navbar-nav-item-link">Events <i class="fa-solid fa-chevron-down"></i></a> <div class="navbar-subnav"> <div class="subnav-graphics"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Header%20Events.jpg" class="subnav-image"> </div> <div class="subnav-items"> <div class="subnav-item flex-3 divider g-20"> <div class="subnav-item-content bottom-mp-fix"> <h3> In-Person & Online Events </h3> <p>Pivotal moments where high-level industry experts and thought leaders come together for focused knowledge sharing and unparalleled networking opportunities.</p> </div> <div class="subnav-item"> <div class="event-pills"> <a href="/discovery-development/events/discovery-development-europe-2025" class="pill center"> <div class="b">Discovery & Development Europe 2025</div> <div class="heading-smallcaps"> 01 - 02 Jul 2025 | Basel, Switzerland </div> </a> <a href="/discovery-development/events/discovery-development-us-2025" class="pill center"> <div class="b">Discovery & Development US 2025</div> <div class="heading-smallcaps"> 02 - 03 Oct 2025 | San Diego, CA </div> </a> </div> </div> </div> <div class="subnav-item flex-2"> <div class="subnav-item-content bottom-mp-fix"> <h3> Online Activities </h3> <p>Our Monthly Science Exchanges and Webinars keep you connected to the conversation.</p> </div> <div class="online-activities-list flex flex-column g-10">  <div class="online-activity"> <a href="/discovery-development/online#Controlled%20Release%20Formulations" class="cta" target="_blank"> <h3 class="other-resources">26/06/24 - Controlled Release Formulations</h3> </a> </div> </div> <div class="subnav-item-content-more"> <a href="/discovery-development/online" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> All Online Activities</a> </div> </div> </div> </div> </li> <li class="navbar-nav-item"> <a href="#" class="navbar-nav-item-link">Community <i class="fa-solid fa-chevron-down"></i></a> <div class="navbar-subnav"> <div class="subnav-graphics"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Header%20Community.jpg" class="subnav-image"> </div> <div class="subnav-items"> <div class="subnav-item flex flex-1 divider"> <div class="subnav-item-content bottom-mp-fix"> <h3> About </h3> <p>We empower scientific decision-makers from the world’s most innovative biopharma organisations to make informed pipeline decisions in early R&D, accelerating their route from target ID to novel clinical candidate.</p> </div> <div class="subnav-item-content-more"> <a href="/discovery-development/about" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> More Info</a> </div> </div> <div class="subnav-item flex flex-1 divider"> <div class="subnav-item-content bottom-mp-fix"> <h3> Community </h3> <p>Our community extends across the entire early R&D ecosystem, including biopharma, solution providers, start-ups, academics, and investors.</p> </div> <div class="subnav-item-content-more"> <a href="/discovery-development/community" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> More Info</a> </div> </div> <div class="subnav-item flex flex-1 "> <div class="subnav-item-content bottom-mp-fix"> <h3> Media Partners </h3> <p>We work with leading journal publications on reciprocal marketing arrangements.</p> </div> <div class="subnav-item-content-more"> <a href="/discovery-development/media-partners" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> More Info</a> </div> </div> </div> </div> </li> <li class="navbar-nav-item"> <a href="#" class="navbar-nav-item-link">Services <i class="fa-solid fa-chevron-down"></i></a> <div class="navbar-subnav"> <div class="subnav-graphics"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Header%20Services.jpg" class="subnav-image"> </div> <div class="subnav-items"> <div class="subnav-item flex flex-1 divider"> <div class="subnav-item-content bottom-mp-fix"> <h3> In-Person Services </h3> <p>At Oxford Global, our events are designed to connect key life science figures and innovative solution providers, accelerating scientific advancement. Our goal is to create valuable connections and an impactful experience through innovative and collaborative formats.</p> </div> <div class="subnav-item-content-more"> <a href="/discovery-development/in-person-services" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> More Info</a> </div> </div> <div class="subnav-item flex flex-1"> <div class="subnav-item-content bottom-mp-fix"> <h3> Digital Marketing Services </h3> <p>Oxford Global’s products offer a powerful channel to associate your brand with the latest advancements within the industry whilst educating and influencing the industry throughout their buying process.</p> </div> <div class="subnav-item-content-more"> <a href="/discovery-development/digital-marketing-services" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> More Info</a> </div> </div> </div> </div> </li> <li class="navbar-nav-item"> <a href="#" class="navbar-nav-item-link">Resources <i class="fa-solid fa-chevron-down"></i></a> <div class="navbar-subnav"> <div class="subnav-graphics"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Header%20Resources.jpg" class="subnav-image"> </div> <div class="subnav-items"> <div class="subnav-item flex-2 divider"> <div class="subnav-item-content bottom-mp-fix"> <h3> Browse All Resources </h3> <p>Scientific & technical insights on the latest targets, platforms and processes impacting drug discovery & development.</p> </div> <div class="subnav-item-content-more"> <a href="/discovery-development/resources" class="subnav-item-content-more-link"><i class="fa-solid fa-circle-chevron-right"></i> All Discovery & Development Resources</a> </div> </div> <div class="subnav-item flex-4 divider"> <div class="subnav-item-content bottom-mp-fix"> <h3> Latest Resources </h3> <div class="resources"> <div class="resource"> <div class="resource-cover"> <a href="/discovery-development/resources/biomedgpt-adopting-a-generalist-approach-to-biomedical-ai" class="resource-cover-link"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Resources/Discovery%20and%20Development/BiomedGPT%20Adopting%20a%20Generalist%20Approach%20to%20Biomedical%20AI%20.png" class="resource-cover-image"> </a> </div> <div class="resource-content"> <h3 class="resource-heading"> <a href="/discovery-development/resources/biomedgpt-adopting-a-generalist-approach-to-biomedical-ai">BiomedGPT: Adopting a Generalist Approach to Biomedical AI </a> </h3> <div class="resource-abstract"> <span class="resource-date">11/11/24 - </span> BiomedGPT, a versatile AI tool used for biomedical research demonstrated impressive results across a wide range of healthcare tasks. </div> </div> </div> <div class="top-divider"></div> <div class="resource"> <div class="other-resources"><a href="/discovery-development/resources/the-application-of-rnai-therapeutics-for-cardiovascular-disease-treatment">07/11/24 - The Application of RNAi Therapeutics for Cardiovascular Disease Treatment</a></div> </div> <div class="top-divider"></div> <div class="resource"> <div class="other-resources"><a href="/discovery-development/resources/ai-ml-advancements-in-drug-formulation-the-potential-of-self-driving-labs">16/10/24 - AI/ML Advancements in Drug Formulation – The Potential of Self-Driving Labs </a></div> </div> </div> </div> </div> <div class="subnav-item flex-3"> <div class="subnav-item-content bottom-mp-fix"> <h3> Featured Resource </h3> <div class="resources flex flex-column g-5"> <a href="https://oxfordglobal.com/discovery-development/resources/sponsored/case-studies/ardigen/advancing-drug-discovery-through-innovative-technologies-strategic-collaboration"> <div class="sponsor-resource flex-column"> <div class="resource-cover img-fluid"> <div class="sponsor-resource-cover-link"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Resources/Discovery/Advancing%20Drug%20Discovery%20Mock%20Up.png" class="sponsor-resource-bubble-image"> </div> </div> <div class="resource-content p-15"> <h3 class="resource-heading"> Advancing Drug Discovery Through Innovative Technologies & Strategic Collaboration </h3> <div class="resource-abstract"> A Concise Report Featuring Insights From The Prominent Thought Leaders Of Discovery & Automate 2024 </div> </div> </div> </a> </div> </div> </div> </div> </div> </li> <li class="navbar-nav-item show-sm hide-md hide-lg hide-xl"> <a href="javascript:postMessage({type:'HS_DISPLAY_CALL_TO_ACTION',id:130207947529});" class="navbar-nav-item-link">Contact</a> </li> <li class="navbar-nav-item show-sm hide-md hide-lg hide-xl"> <a href="#" class="navbar-nav-item-link">Our Brands <i class="fa-solid fa-chevron-down"></i></a> <div class="navbar-subnav"> <div class="subnav-items"> <h2> Explore our brands </h2> <div class="desc"> Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges. </div> <div class="subnav-item"> <div class="subnav-item-content"> <a href="/">Oxford Global</a> </div> </div> <div class="subnav-item"> <div class="subnav-item-content"> <a href="/precision-medicine">Precision Medicine</a> </div> </div> <div class="subnav-item"> <div class="subnav-item-content"> <a href="/discovery-development">Discovery & Development</a> </div> </div> <div class="subnav-item"> <div class="subnav-item-content"> <a href="/nextgen-biomed">NextGen Biomed</a> </div> </div> </div> </div> </li> </ul> </div> <div class="flex flex-align-center hide-sm show-md show-lg show-xl"> <a href="javascript:postMessage({type:'HS_DISPLAY_CALL_TO_ACTION',id:130207947529});" class="navbar-button">Contact</a> </div> </div> </header></div> <main id="main-content"> <div class="resource-single"> <div class="header bg-primary-light"> <div class="container-wrapper"> <div class="wide-container header-container"> <div class="header-content flex-1"> <div class="heading-smallcaps"> Molecular Drug Design | Industry Spotlights & Insight Articles </div> <h1 class="heading"> From Theory to Therapy: Accelerating Ligand-Based Virtual Screening with AI and ML Technologies </h1> <div class="byline"> 01 February 2024 </div> <div class="abstract"> Discover the transformative role of AI and ML in improving ligand-based virtual screening outcomes, from breakthrough drug candidate identification to overcoming challenges in data quality and computational resources </div> </div> <div class="header-graphic flex-1"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Resources/Discovery/Accelerating%20Ligand-Based%20Virtual%20Screening%20with%20AI%20and%20ML%20Technologies.jpg" class="header-graphic-image"> </div> </div> </div> </div> <div class="container-wrapper"> <div class="wide-container"> <div class="content"> <div class="content-body text-gap"> <p>Ligand-based virtual screening (LBVS) represents a cornerstone in the drug discovery process, offering a computational approach to identifying novel compounds that may bind to specific biological targets. This methodology hinges on the principle that molecules similar in structure are likely to exhibit similar biological activities. Traditionally, LBVS has enabled researchers to sift through vast chemical spaces, pinpointing candidates for further experimental validation. However, the approach is not without its challenges, including the handling of vast datasets and the complexity of molecular interactions.</p> <p>However, Artificial Intelligence (AI) and Machine Learning (ML) technologies have started to significantly impact various scientific fields, with drug discovery being no exception. AI and ML promise to transcend traditional LBVS limitations by harnessing computational power to process and learn from data in unprecedented ways. This month, <a href="https://oxfordglobal.com/discovery"><span>Discovery By Oxford Global</span></a> dives into the transformative role of AI and ML in ligand-based virtual screening, exploring how these technologies are not just enhancing but revolutionizing the process, making it more accurate, efficient, and innovative</p> <h2><span style="color: #37761d;"><strong>Understanding Ligand-Based Virtual Screening</strong></span></h2> <p>Ligand-based virtual screening is a method used in the early stages of drug discovery to identify molecules that could bind to a biological target of interest, typically a protein that plays a role in disease. Unlike structure-based methods that require a detailed 3D structure of the target, LBVS relies on information from known ligands—molecules already known to interact with the target.</p> <p>The process involves comparing the chemical properties and structures of potential ligands against those of known active compounds. By employing various computational techniques, such as similarity searching, pharmacophore modeling, and machine learning algorithms, LBVS predicts the likelihood of a compound being active against a target.</p> <h2><span style="color: #37761d;"><strong>Applications and Challenges</strong></span></h2> <p>LBVS has been instrumental in identifying lead compounds in several therapeutic areas. However, the method faces significant challenges, including the need for large, high-quality datasets of ligands and the complexity of accurately modeling molecular interactions. The inherent limitations of traditional computational methods in handling the dynamic and multifaceted nature of biological systems further complicate the screening process.</p> <h2><span style="color: #37761d;"><strong>Fundamentals of AI and ML in Drug Discovery</strong></span></h2> <p>AI and ML stand out in drug discovery for their ability to learn from and make predictions based on data. These technologies can uncover patterns and insights from complex datasets much more efficiently than human researchers or traditional computational methods.</p> <h3><strong>Types of ML Models in LBVS</strong></h3> <ul> <li><strong>Supervised Learning:</strong> <br>These models are trained on labeled datasets, making them suitable for predicting the activity of new compounds based on prior knowledge.<br><br></li> <li><strong>Unsupervised Learning:</strong> <br>Useful in identifying novel patterns or clusters within data without predefined labels, unsupervised learning can help uncover unknown ligand-target relationships.<br><br></li> <li><strong>Reinforcement Learning:</strong> <br>This approach enables models to learn optimal actions through trial and error, offering potential in optimizing screening strategies and decision-making processes in drug design.</li> </ul> <h2><span style="color: #37761d;"><strong>AI and ML Enhancements in LBVS</strong></span></h2> <p>The integration of AI and ML into LBVS has led to notable improvements across various facets of the screening process:</p> <ul> <li><strong>Feature Selection and Dimensionality Reduction<br></strong>AI and ML excel in identifying the most relevant features of ligands that contribute to biological activity, streamlining the representation of compounds and enhancing the screening's accuracy.</li> </ul> <ul> <li><strong>Improved Prediction Models<br></strong>ML algorithms, especially deep learning, have demonstrated superior performance in predicting binding affinity and specificity, leveraging complex representations of molecular structures and interactions.</li> </ul> <ul> <li><strong>Novel Ligand-Target Interactions</strong><br>Deep learning models, through their ability to learn high-level features from data, have shown promise in identifying previously unknown ligand-target interactions, opening new avenues for drug discovery.</li> </ul> <h3><span style="color: #37761d;"><strong>Case Studies: AI and ML in Action</strong></span></h3> <p>The transformative impact of AI and ML on ligand-based virtual screening (LBVS) is best illustrated through specific case studies that showcase their potential in revolutionizing drug discovery.</p> <ul> <li><strong>Breakthroughs in Identifying New Drug Candidates<br></strong><span>One notable example</span> is the use of <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052301/" rel="noopener" target="_blank"><strong>deep learning models</strong></a> to identify potential inhibitors for the Ebola virus. Researchers utilized a convolutional neural network to screen over one million compounds, resulting in the discovery of new compounds that showed high binding affinity to the Ebola protein, which were later confirmed through laboratory tests. This success story underscores the efficiency and accuracy of AI in identifying <strong><a href="https://oxfordglobal.com/discovery/resources/using-ml-with-del-philogen-and-google-partner-in-new-study?hsLang=en">viable drug candidates from vast chemical libraries.</a></strong><br><br></li> <li><strong>Integration in LBVS Workflows<br></strong>Another significant advancement is the integration of ML algorithms into existing LBVS workflows to enhance the prediction of drug-likeness and pharmacokinetic properties of molecules. For instance, a pharmaceutical company implemented an AI-driven platform to refine their screening process, resulting in a 50% reduction in time to identify lead compounds with optimal properties. This integration demonstrates how AI and ML can streamline drug discovery processes, making them more efficient and cost-effective.</li> </ul> <h3><span style="color: #37761d;"><strong>Overcoming Challenges with AI and ML in LBVS</strong></span></h3> <p>Despite their potential, the application of AI and ML in LBVS faces<strong> <a href="https://oxfordglobal.com/discovery/resources/using-ai-to-drive-drug-design-maximising-the-impact-of-big-data-with-computer-aided-drug-discovery" rel="noopener" target="_blank">several challenges</a></strong> that researchers are actively working to overcome.</p> <ul> <li><strong>Data Quality and Availability Issues<br></strong>High-quality, annotated datasets are crucial for training accurate and reliable ML models. Efforts to address this include the development of public databases and the use of data augmentation techniques to enhance the diversity and quality of datasets available for training.<br><br></li> <li><strong>Computational Resource Constraints<br></strong>The computational demands of AI and ML models, particularly deep learning algorithms, can be substantial. Cloud computing <strong><a href="https://oxfordglobal.com/discovery/resources/mrna-vaccine-development-to-get-a-quantum-boost?hsLang=en">and specialized hardware</a></strong>, such as GPUs, are increasingly being utilized to meet these demands, enabling more complex models to be trained more efficiently.<br><br></li> <li><strong>Ethical Considerations and Bias Mitigation<br></strong>Ensuring fairness and avoiding bias in AI-driven LBVS is paramount. Initiatives to address this involve the implementation of bias detection and mitigation strategies during model training, as well as the development of transparent AI systems that allow for the scrutiny of decision-making processes.</li> </ul> <h3><span style="color: #37761d;"><strong>Future Directions and Potentials</strong></span></h3> <p>The future of AI and ML in LBVS is bright, with emerging trends poised to further enhance the drug discovery landscape.</p> <ul> <li><strong>Emerging Trends<br></strong>Advancements in AI techniques, such as transfer learning and <strong><a href="https://www.techtarget.com/searchenterpriseai/definition/generative-adversarial-network-GAN">generative adversarial networks (GANs)</a></strong>, hold promise for creating more accurate and generalizable models. These techniques can potentially reduce the need for extensive datasets and enable the discovery of entirely novel chemical entities.</li> </ul> <ul> <li><strong>Impact on Drug Discovery<br></strong>The continued integration of AI and ML is expected to significantly impact <strong><a href="https://oxfordglobal.com/discovery/resources/the-highs-and-lows-of-applying-ai-to-drug-design?hsLang=en">the speed, cost, and success rates of drug discovery</a></strong>. By enabling more precise predictions and efficient screenings, these technologies can reduce the time from initial screening to clinical trials, lower R&D costs, and increase the likelihood of discovering viable drug candidates.</li> </ul> <h3><span style="color: #37761d;"><strong>Conclusion</strong></span></h3> <p>The integration of AI and ML into ligand-based virtual screening represents a pivotal shift in drug discovery, offering unprecedented opportunities to enhance efficiency, accuracy, and innovation. Through specific case studies, we've seen the tangible benefits these technologies bring, from breakthroughs in identifying new drug candidates to streamlining existing workflows. While challenges remain, ongoing efforts to address data quality, computational resources, and ethical considerations are paving the way for a future where AI and ML play a central role in discovering the next generation of therapeutic agents. The importance of continued innovation in these technologies cannot be overstated, as they hold the key to advancing LBVS and revolutionizing the field of drug discovery.</p> <p><em>Get your weekly dose of industry news </em><a href="https://oxfordglobal.com/discovery/resources"><em><span style="color: blue;">here</span></em></a><em> and keep up to date with the latest ‘Industry Spotlight’ posts.</em> <em>For other Discovery content, please visit the</em> <a href="https://oxfordglobal.com/discovery/?hsLang=en"><em><span style="color: blue;">Discovery Content Portal</span></em></a><em>.</em> </p> <div class="content-body-footer"> </div> </div> <div class="content-sidebar"> <div class="related-articles"> <h3 class="center">Related Resources</h3> <div class="article"> <a href="/discovery-development/resources/biomedgpt-adopting-a-generalist-approach-to-biomedical-ai"> <div class="cover-graphic"> <img src="https://oxfordglobal.com/hubfs/Website/Images/Resources/Discovery%20and%20Development/BiomedGPT%20Adopting%20a%20Generalist%20Approach%20to%20Biomedical%20AI%20.png" class="cover-graphic-image"> </div> </a><div class="content"><a href="/discovery-development/resources/biomedgpt-adopting-a-generalist-approach-to-biomedical-ai"> <h4> BiomedGPT: Adopting a Generalist Approach to Biomedical AI </h4> <div class="abstract"> BiomedGPT, a versatile AI tool used for biomedical research demonstrated impressive results across a wide range of healthcare tasks. </div> <div class="read-more"> <a href="/discovery-development/resources/biomedgpt-adopting-a-generalist-approach-to-biomedical-ai" class="read-more-link">Read More</a> </div></a> </div> </div> <div class="article"> <a href="/discovery-development/resources/goserelin-acetate-vitaldose-eva-implant"> <div class="cover-graphic"> <img src="https://oxfordglobal.com/hubfs/Website/Documents/White%20paper%20upload%20LS%206-11-24/Discovery%20%26%20Development%20Whitepaper.png" class="cover-graphic-image"> </div> </a><div class="content"><a href="/discovery-development/resources/goserelin-acetate-vitaldose-eva-implant"> <h4> Goserelin Acetate – VitalDose® EVA Implant </h4> <div class="abstract"> </div> <div class="read-more"> <a href="/discovery-development/resources/goserelin-acetate-vitaldose-eva-implant" class="read-more-link">Read More</a> </div></a> </div> </div> </div> </div> </div> </div> </div> </div> <div class="newsletter-cta"> <h2 class="heading">Subscribe to our newsletter</h2> <div class="message"> Sign up for our monthly Newsletter to keep up with all things Discovery & Development </div> <div class="button-wrapper"> <a href="#" class="button hs-cta-trigger-button hs-cta-trigger-button-177049184347">Newsletter Sign-Up</a> </div> </div> </main> <div data-global-resource-path="git/og-stage/templates/partials/footer.html"><footer class="website-footer flex flex-column g-20"> <div class="footer-columns"> <div class="footer-column"> <a href="https://oxfordglobal.com" class="site-logo-link"> <img src="https://oxfordglobal.com/wp-content/uploads/2023/03/Oxford-Global-Logo-Stacked-Websize.png" class="site-logo"> </a> </div> <div class="footer-column"> <h3>Brands</h3> <ul> <li> <a href="/precision-medicine/">Precision Medicine</a> </li> <li> <a href="/discovery-development/">Discovery & Development</a> </li> <li> <a href="/nextgen-biomed/">NextGen Biomed</a> </li> </ul> </div> <div class="footer-column"> <h3>Services</h3> <ul> <li> <a href="https://oxfordglobal.com/in-person-services/"> In-Person Services </a> </li> <li> <a href="https://oxfordglobal.com/digital-marketing-services/"> Digital Marketing Services </a> </li> </ul> <h3>Upcoming Events</h3> <ul> <li> <a href="https://oxfordglobal.com/calendar/"> Event Calendar </a> </li> </ul> </div> <div class="footer-column"> <h3>Company</h3> <ul> <li class="elementor-icon-list-item"> <a href="https://oxfordglobal.com/about-us/"> About </a> </li> <li class="elementor-icon-list-item"> <a href="https://oxfordglobal.com/vacancies/"> Vacancies </a> </li> <li class="elementor-icon-list-item"> <a href="https://oxfordglobal.com/csr-policy/"> CSR Policy </a> </li> <li class="elementor-icon-list-item"> <a href="javascript:postMessage({type:'HS_DISPLAY_CALL_TO_ACTION',id:130207947529});"> Contact </a> </li> </ul> </div> <div class="footer-column"> <p> <a href="tel:+441865248455">+44 1865 248 455</a><br> <a href="mailto:help@oxfordglobal.com">help@oxfordglobal.com</a> </p> <p> <strong>Our UK Address:</strong><br> Godstow Court<br> Minns Business Park<br> Botley<br> Oxford, OX2 0JB </p> <p> <strong>Our US Address:</strong><br> 100 Cambridge Street<br> 14th Floor<br> Boston<br> MA 02114 </p> </div> </div> <div class="footer-bottom grid g-20"> <div class="span8 span12-sm span12-md flex flex-column g-10"> <div class="copyright"> © Oxford Global Marketing Ltd. All rights reserved. </div> <ul class="legal-links flex flex-row g-30 flex-column-sm g-sm-10"> <li><a href="https://oxfordglobal.com/legal/">Terms & Conditions</a></li> <li><a href="https://oxfordglobal.com/legal/privacy-policy/">Privacy Policy</a></li> <li><a href="https://oxfordglobal.com/legal/website-terms/">Cookies</a></li> <li><a href="https://www.wishagency.co.uk/" target="_BLANK">Digital Agency Wish</a></li> </ul> </div> <div class="span4 span12-sm span12-md flex-align-end"> <ul class="social-links flex flex-row flex-justify-end flex-justify-center-sm flex-justify-center-md g-30"> <li><a href="https://www.facebook.com/OGConferences/" target="_BLANK"><i class="fa-brands fa-square-facebook"></i></a></li> <li><a href="https://www.linkedin.com/company/oxford-global/" target="_BLANK"><i class="fa-brands fa-linkedin"></i></a></li> <li><a href="https://twitter.com/OGConferences" target="_BLANK"><i class="fa-brands fa-square-x-twitter"></i></a></li> </ul> </div> </div> </footer></div> </div> <script src="/hs/hsstatic/jquery-libs/static-1.1/jquery/jquery-1.7.1.js"></script> <script>hsjQuery = window['jQuery'];</script>  <script defer src="/hs/hsstatic/content-cwv-embed/static-1.1293/embed.js"></script> <script src="https://oxfordglobal.com/hs-fs/hub/8696823/hub_generated/template_assets/182600797781/1731148644227/git/og-stage/js/inlineSVG.min.js"></script> <script src="https://oxfordglobal.com/hs-fs/hub/8696823/hub_generated/template_assets/135724366742/1725380923802/git/og-stage/js/main.min.js"></script> <script> function getVideoId(url) { var regExp = /^.*(youtu.be\/|v\/|u\/\w\/|embed\/|watch\?v=|\&v=)([^#\&\?]*).*/; var match = url.match(regExp); if (match && match[2].length == 11) { return match[2]; } else { return false; } } function getVideoEmbed(id) { return '<iframe src="https://www.youtube.com/embed/' + id + '" title="YouTube video player" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" allowfullscreen style="aspect-ratio: 16 / 9; width: 100%;"></iframe>'; } jQuery("div.content-body .wp-block-embed__wrapper:contains('youtu')").each(function() { var yt_url = $(this).html().trim(); var yt_id = getVideoId(yt_url); var yt_embed = getVideoEmbed(yt_id); $(this).html(yt_embed); }); </script>  <script type="text/javascript"> var _hsq = _hsq || []; _hsq.push(["setContentType", "standard-page"]); _hsq.push(["setCanonicalUrl", "https:\/\/oxfordglobal.com\/discovery-development\/resources\/accelerating-ligand-based-virtual-screening"]); _hsq.push(["setPageId", "hubdb-177028096592-7642658-170712574356"]); _hsq.push(["setContentMetadata", { "contentPageId": "hubdb-177028096592-7642658-170712574356", "legacyPageId": "hubdb-177028096592-7642658-170712574356", "contentFolderId": null, "contentGroupId": null, "abTestId": null, "languageVariantId": 177028096592, "languageCode": "en", }]); </script> <script type="text/javascript" id="hs-script-loader" async defer src="/hs/scriptloader/8696823.js"></script>  <script type="text/javascript"> var hsVars = { render_id: "3d44676f-26a3-47e1-8774-e2c63ed0b32e", ticks: 1732665856352, page_id: 177028096592, dynamic_page_id: "hubdb-177028096592-7642658-170712574356", content_group_id: 0, portal_id: 8696823, app_hs_base_url: "https://app.hubspot.com", cp_hs_base_url: "https://cp.hubspot.com", language: "en", analytics_page_type: "standard-page", scp_content_type: "", analytics_page_id: "hubdb-177028096592-7642658-170712574356", category_id: 1, folder_id: 0, is_hubspot_user: false } </script> <script defer src="/hs/hsstatic/HubspotToolsMenu/static-1.354/js/index.js"></script> </body></html>

CINXE.COM

From Theory to Therapy: Accelerating Ligand-Based Virtual Screening with AI and ML Technologies